Intravenous ALP-1 to maintain stability in advanced heart failure
Part of Heart & circulation clinical trials.
This study tests a medicine called ALP-1, given as a continuous IV infusion, to see if it can help keep people with advanced heart failure stable and out of the hospital. It may help if you have severe heart failure despite being on all recommended treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have advanced heart failure with a very low ejection fraction (less than 30%) – a measure of how well your heart pumps.
- Your heart failure symptoms must be severe – you feel short of breath or tired even at rest or with little effort.
- You must be on all recommended standard heart failure treatments.
- You must not be currently receiving ongoing IV (intravenous) heart medicines at home.
- You must not be scheduled for a heart transplant or a mechanical heart pump (LVAD) within the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study is looking at a new treatment for people with heart failure where the heart’s pumping strength is not reduced much (HFpEF or HFmrEF), but pressure inside the heart is high during exercise. It may help relieve symptoms in people who still feel unwell during normal activity despite stable standard treatment.
This study tests a new device or procedure to help people with heart failure and a weak heart pump. If you have a low ejection fraction and are on standard medications, you may be able to join.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This trial is studying a non-surgical (conservative) treatment approach for people being considered for a left ventricular assist device (LVAD). It may help some patients who are too sick or unable to tolerate standard heart failure medicines, but it will only match people with specific heart function and health-test results.
This trial tests whether lipoic acid can help people with long-term heart failure. It may improve how well your heart works. The study lasts for a period of time and you will take the study medicine or a placebo (a pill with no active ingredient).
Hear when a new End Stage Cardiac Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.